Factors influencing unmet needs among triple-negative breast cancer survivors

被引：0
|
作者：
Ryeong, Bae Ka [1 ]
机构：
[1] Sungkyunkwan Univ, SAIHST, Seoul, South Korea
来源：
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING | 2024年 / 11卷
关键词：
Cancer Survivors; Triple Negative Breast Neoplasms; Needs Assessment; Republic of Korea;
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    [J]. LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [42] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    [J]. Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [43] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [44] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    [J]. MEDICAL ONCOLOGY, 2018, 35 (01)
  • [45] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    [J]. Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269
  • [46] Characteristics of triple-negative breast cancer
    Tim C. de Ruijter
    Jürgen Veeck
    Joep P. J. de Hoon
    Manon van Engeland
    Vivianne C. Tjan-Heijnen
    [J]. Journal of Cancer Research and Clinical Oncology, 2011, 137 : 183 - 192
  • [47] Triple-negative breast cancer in the elderly
    Shagisultanova, Elena
    Mayordomo, Jose
    Elias, Anthony D.
    [J]. BREAST JOURNAL, 2017, 23 (06): : 627 - 629
  • [48] An overview of triple-negative breast cancer
    Kumar, Pankaj
    Aggarwal, Rupali
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (02) : 247 - 269
  • [49] Male Triple-Negative Breast Cancer
    Qavi, Qasif
    Alkistawi, Firas
    Kumar, Shashi
    Ahmed, Rizwan
    Al-Zawi, Abdalla Saad Abdalla
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [50] Pharmacotherapy of triple-negative breast cancer
    Arslan, Cagatay
    Dizdar, Omer
    Altundag, Kadri
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2081 - 2093
12345